The FDA said last week after Vioxx was withdrawn that the problems were unique to that drug .
Merck 's decision to withdraw Vioxx cast suspicion on the safety of drugs in that class .
`` I did have a patient who said , ' I 've heard about Vioxx , I hear Celebrex is next . '
`` This morning Merck is announcing a voluntary worldwide withdrawal of Vioxx , '' Gilmartin began .
`` The data for Celebrex is robust and exceeds , in the length of patients in studies and in the size of studies , the data Vioxx has , '' she said .